Autopsy report · NCT02779192

A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Study did not start”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Sound Pharmaceuticals, Incorporated
Sponsor type: Industry
Conditions: Noise Induced Hearing Loss
Interventions: SPI-1005 200mg; SPI-1005 400mg; Placebo
Participants: 0
Sites: 5
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.